Company Overview of Stemina Biomarker Discovery, Inc.
Stemina Biomarker Discovery, Inc., a metabolomics company, focuses on the discovery, development, and commercialization of molecular biomarkers to improve drug safety and human health. The company works on collaborative research projects and joint development agreements with strategic partners to develop drugs, identify targets, and discover molecular biomarkers for the diagnosis of diseases and customized treatment. It provides metabolomics and mass spectrometry services, as well as develops diagnostic biomarkers. The company’s cell-based assays arise from the strategic convergence of technologies, such as human embryonic stem (hES) cells and metabolomics. It uses mass spectrometry to analy...
504 South Rosa Road
Madison, WI 53719
Founded in 2006
Key Executives for Stemina Biomarker Discovery, Inc.
Chief Executive Officer and Director
Director of BioAnalytical Chemistry
Senior Scientist of BioAnalytical Chemistry
Compensation as of Fiscal Year 2015.
Stemina Biomarker Discovery, Inc. Key Developments
Stemina Presents at 2014 Autism Investment Conference, Mar-04-2014 09:00 AM
Feb 24 14
Stemina Presents at 2014 Autism Investment Conference, Mar-04-2014 09:00 AM. Venue: Bently Reserve, 301 Battery St, San Francisco, CA 94111, United States. Speakers: Marc Schneebaum, Head of Stemina Diagnostics.
Stemina Biomarker Receives Contract to Test for Toxins from U.S. Environmental Protection Agency
Jan 9 14
Stemina Biomarker has won a five-year, $10.6 million contract for its devTOX technology from the U.S. Environmental Protection Agency.
Stemina Biomarker Discovery, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013 01:30 PM
Oct 1 13
Stemina Biomarker Discovery, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013 01:30 PM. Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
December 31, 2014